Vitamin K for the treatment of asymptomatic coagulopathy associated with oral anticoagulant therapy

Journal of Thrombosis and Thrombolysis

Volumn 16, Issue 1-2, 2003, Pages 69-72

  Crowther, Mark A ^a   Wilson, Sarah ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Hemorrhage; INR; Vitamin K; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; PHYTOMENADIONE; VITAMIN K GROUP; WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING; BLOOD CLOTTING DISORDER; DOSE RESPONSE; DRUG EFFICACY; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; HEART INFARCTION; HUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

ADMINISTRATION, ORAL; ANTICOAGULANTS; DISSEMINATED INTRAVASCULAR COAGULATION; HUMANS; VITAMIN K;

EID: 1842627560     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:THRO.0000014597.87575.e9     Document Type: Review

References (16)

1. McMahon DA, Smith DM, Carey MA, Zhou XH. Risk of major hemorrhage for outpatients treatment with warfarin. Journal Gen Intern Med 1998;13:311-316.
2. Samsa GP, Matchar DB, Goldstein LB, et al. Quality of anticoagulation management among patients with atrial fibrillation: Results of a review of medical records from 2 communities. Arch Intern Med 2000;160:967-973.
3. Oden A, Fahlen M. Oral anticoagulation and risk of death: A medical record linkage study. BMJ 2002;325(7372): 1073-1075.
4. Kearon C, Ginsberg JS, Kovacs MJ, et al. Low-intensity (INR 1.5-1.9) versus conventional-intensity (INR 2.0-3.0) anticoagulation for extended treatment of unprovoked VTE: A randomized double blind trial. Blood 2002;100:150a (Abs. 562).
5. Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996;348(9025):423-428.
6. Wilson SE, Douketis JD, Crowther MA. Treatment of warfarin-associated coagulopathy: A physician survey. Chest 2001;120:1972-1976.
7. Libby EN, Garcia DA. A survey of oral vitamin K use by anticoagulation. clinics. Arch Intern Med 2002;162:1893-1896.
8. Crowther MA, Douketis JD, Schnurr T, et al. Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial. Ann Intern Med 2002;137:251-254.
9. 1 in reversing excessive oral anticoagulation. American Journal of Cardiology 1999;83:286-288.
10. Raj G, Kumar R, McKinney WP. Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione. Arch Intern Med 1999;159:2721-2724.
11. Watson HG, Baglin T, Laidlaw SL, Makris M, Preston FE. A comparison of the efficacy and rate of response to oral and intravenous vitamin K in reversal of over-anticoagulation with warfarin. Br J Haematol 2001;115:145-149.
12. Crowther MA, Donovan D, Harrison L, McGinnis J, Ginsberg J. Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin. Thrombosis and Haemostasis 1998;79:1116-1118.
13. Crowther MA, Julian J, Douketis JD, et al. Treatment of warfarin-associated coagulopathy with oral vitamin K: A randomized clinical trial. Lancet 2000;356:1551-1553.
14. Duong TM, Plowman BK, Morreale AP, Janetzky K. Retrospective and prospective analyses of the treatment of over-anticoagulated patients. Pharmacotherapy 1998;18:1264-1270.
15. Patel RJ, Witt DM, Saseen JJ, Tillman DJ, Wilkinson DS. Randomized, placebo-controlled trial of oral phytonadione for excessive articoagulation. Pharmacotherapy 2000;20:1159-1166.
16. Pendry K, Bhavnani M, Shwe K. The use of oral vitamin K for reversal of over-warfarinization. Br J Haematol 2001; 113:839-840.